The neurobiology of gliomas: from cell biology to the development of therapeutic approaches

Gliomas are the most common type of primary brain tumour and are often fast growing with a poor prognosis for the patient. Their complex cellular composition, diffuse invasiveness and capacity to escape therapies has challenged researchers for decades and hampered progress towards an effective treatment. Recent molecular characterization of tumour cells combined with new insights into cellular diversification that occurs during development, and the modelling of these processes in transgenic animals have enabled a more detailed understanding of the events that underlie gliomagenesis. Combining this enhanced understanding of the relationship between neural stem cell biology and the cell lineage relationships of tumour cells with model systems offers new opportunities to develop specific and effective therapies.

[1]  P. Varlet,et al.  Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  H. Fine,et al.  Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchy , 2011, Glia.

[3]  Aiguo Li,et al.  GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes , 2010, BMC Medical Informatics Decis. Mak..

[4]  Elizabeth Gould,et al.  How widespread is adult neurogenesis in mammals? , 2007, Nature Reviews Neuroscience.

[5]  A. Smits,et al.  Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma , 2009, Oncogene.

[6]  Pieter Wesseling,et al.  Molecular diagnostics of brain tumors , 2010, Acta Neuropathologica.

[7]  Jun Lin,et al.  γ-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells. , 2010, Archives of medical research.

[8]  A. Kakita,et al.  Patterns and Dynamics of SVZ Cell Migration in the Postnatal Forebrain Monitoring Living Progenitors in Slice Preparations , 1999, Neuron.

[9]  R. McKay,et al.  CNS stem cells express a new class of intermediate filament protein , 1990, Cell.

[10]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[11]  J. S. Rao,et al.  Molecular mechanisms of glioma invasiveness: the role of proteases , 2003, Nature Reviews Cancer.

[12]  U. Lendahl,et al.  Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system. , 1995, Brain research. Developmental brain research.

[13]  M. Götz.  Glial Cells Generate Neurons—Master Control within CNS Regions: Developmental Perspectives on Neural Stem Cells , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[14]  F. Lefranc.  Editorial: on the road to multi-modal and pluri-disciplinary treatment of glioblastomas , 2009, Acta Neurochirurgica.

[15]  Bin Wang,et al.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. , 2011, Cancer cell.

[16]  A. Guha,et al.  Expression of GATA6 in the human and mouse central nervous system. , 2005, Brain research. Developmental brain research.

[17]  M. Eddleston,et al.  Molecular profile of reactive astrocytes—Implications for their role in neurologic disease , 1993, Neuroscience.

[18]  K. Aldape,et al.  Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth , 2007, Proceedings of the National Academy of Sciences.

[19]  James E. Goldman,et al.  Multiple Cell Populations in the Early Postnatal Subventricular Zone Take Distinct Migratory Pathways: A Dynamic Study of Glial and Neuronal Progenitor Migration , 2003, The Journal of Neuroscience.

[20]  K. Mori,et al.  Essential Roles of Notch Signaling in Maintenance of Neural Stem Cells in Developing and Adult Brains , 2010, The Journal of Neuroscience.

[21]  B. Scheithauer,et al.  Microglia in brain tumors , 2002, Glia.

[22]  N. Gaiano,et al.  Notch signaling in the mammalian central nervous system: insights from mouse mutants , 2005, Nature Neuroscience.

[23]  C. Beaudry,et al.  Glioma cells on the run – the migratory transcriptome of 10 human glioma cell lines , 2008, BMC Genomics.

[24]  M. Esteller.  CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.

[25]  Webster K. Cavenee,et al.  A Drosophila Model for EGFR-Ras and PI3K-Dependent Human Glioma , 2009, PLoS genetics.

[26]  Timothy F. Cloughesy,et al.  Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment , 2005, Clinical Cancer Research.

[27]  D. Benos,et al.  CD133 Is a Marker of Bioenergetic Stress in Human Glioma , 2008, PloS one.

[28]  C. Miller,et al.  Glioblastoma: Morphologic and molecular genetic diversity , 2007 .

[29]  T. Golde,et al.  Targeting Notch to Target Cancer Stem Cells , 2010, Clinical Cancer Research.

[30]  J. Faijerson.  NEURAL STEM/PROGENITOR CELLS IN THE POST-ISCHEMIC ENVIRONMENT: Proliferation, Differentiation and Neuroprotection , 2007 .

[31]  T. Ludwig,et al.  Glioblastoma Models Reveal the Connection between Adult Glial Progenitors and the Proneural Phenotype , 2011, PloS one.

[32]  Karlyne M. Reilly,et al.  Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum , 2002, Oncogene.

[33]  James E. Goldman,et al.  Cell migration in the normal and pathological postnatal mammalian brain , 2009, Progress in Neurobiology.

[34]  Aaron J. Bell,et al.  Flies as the ointment: Drosophila modeling to enhance drug discovery , 2009, Fly.

[35]  J. Sampson,et al.  Combating immunosuppression in glioma. , 2008, Future oncology.

[36]  Mitchel S Berger,et al.  Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  John A Butman,et al.  Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. , 2007, Journal of neurosurgery.

[38]  C. Klämbt,et al.  Modeling glioma growth and invasion in Drosophila melanogaster. , 2009, Neoplasia.

[39]  R. Wilson,et al.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.

[40]  Maiken Nedergaard,et al.  Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain , 2003, Nature Medicine.

[41]  S. Juliano,et al.  Regulation of neural progenitor cell development in the nervous system , 2008, Journal of neurochemistry.

[42]  L. Miele,et al.  NOTCH signaling as a novel cancer therapeutic target. , 2006, Current cancer drug targets.

[43]  Daniel A. Lim,et al.  Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain , 1999, Cell.

[44]  W. Markesbery,et al.  Relationship of lymphocyte invasion and survival of brain tumor patients , 1978, Annals of neurology.

[45]  J. Uhm,et al.  The transcriptional network for mesenchymal transformation of brain tumours , 2010 .

[46]  K. Hoang-Xuan,et al.  All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2 , 2010, Neurology.

[47]  D. Steindler,et al.  The origins of glioma: E Pluribus Unum? , 2011, Glia.

[48]  G. Fuller,et al.  Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice. , 2004, Neuron glia biology.

[49]  Eric C. Holland,et al.  Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma , 2010, Nature Reviews Cancer.

[50]  John W. Park,et al.  Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. , 2007, Neuro-oncology.

[51]  J. Uhm.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2009 .

[52]  Matteo Pellegrini,et al.  Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. , 2008, Cell stem cell.

[53]  G. Fuller,et al.  Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation★ , 2006, Journal of Neuro-Oncology.

[54]  Hao Jiang,et al.  The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo , 2010, Journal of Neuro-Oncology.

[55]  K. Ligon,et al.  Olig gene function in CNS development and disease , 2006, Glia.

[56]  David N Louis,et al.  Molecular pathology of malignant gliomas. , 2006, Annual review of pathology.

[57]  Monte A. Gates,et al.  Site-Specific Migration and Neuronal Differentiation of Human Neural Progenitor Cells after Transplantation in the Adult Rat Brain , 1999, The Journal of Neuroscience.

[58]  M. Sofroniew.  Molecular dissection of reactive astrogliosis and glial scar formation , 2009, Trends in Neurosciences.

[59]  Serban Nacu,et al.  A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. , 2010, Cancer cell.

[60]  Brian Bierie,et al.  GFAP-Cre–Mediated Activation of Oncogenic K-ras Results in Expansion of the Subventricular Zone and Infiltrating Glioma , 2009, Molecular Cancer Research.

[61]  P. Wen,et al.  Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials. , 2010, Neuroimaging clinics of North America.

[62]  Arturo Alvarez-Buylla,et al.  Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. , 2009, Cancer cell.

[63]  Guido Nikkhah,et al.  NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts , 2009, Stem cells.

[64]  John Sampson,et al.  Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  M. Oshimura,et al.  A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells , 2010, Neurological research.

[66]  H. Kettenmann,et al.  The brain tumor microenvironment , 2011, Glia.

[67]  T. Cloughesy,et al.  Targeted therapy for malignant glioma patients: Lessons learned and the road ahead , 2009, Neurotherapeutics.

[68]  M. Monje,et al.  Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. , 2008, The oncologist.

[69]  B. Christensen,et al.  DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. , 2011, Journal of the National Cancer Institute.

[70]  C. Brennan,et al.  Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations , 2009, PloS one.

[71]  P. Dirks,et al.  Cancer stem cells in nervous system tumors , 2004, Oncogene.

[72]  Robert H Miller,et al.  Control of Astrocyte Migration in the Developing Cerebral Cortex , 2003, Developmental Neuroscience.

[73]  P. Eriksson,et al.  Reactive astrogliosis induces astrocytic differentiation of adult neural stem/progenitor cells in vitro , 2006, Journal of neuroscience research.

[74]  J. Costello,et al.  Epigenetic mechanisms in glioblastoma multiforme. , 2009, Seminars in cancer biology.

[75]  S. Blacklow,et al.  The molecular logic of Notch signaling – a structural and biochemical perspective , 2008, Journal of Cell Science.

[76]  A. Álvarez-Buylla,et al.  Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes , 2010, The EMBO journal.

[77]  R. Kovall.  More complicated than it looks: assembly of Notch pathway transcription complexes , 2008, Oncogene.

[78]  Miguel Alaminos,et al.  A microarray-based DNA methylation study of glioblastoma multiforme , 2009, Epigenetics.

[79]  Caterina Giannini,et al.  The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors , 2005, Cancer.

[80]  Michael A Vogelbaum,et al.  Future of convection-enhanced delivery in the treatment of brain tumors. , 2010, Future oncology.

[81]  I. Radovanovic,et al.  Limits of CD133 as a marker of glioma self‐renewing cells , 2009, International journal of cancer.

[82]  K. Mikoshiba,et al.  Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell. , 1996, Developmental biology.

[83]  J. Shang,et al.  Adenoviral‐mediated interleukin‐18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats , 2009, Cell biology international.

[84]  Mark Noble,et al.  CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo , 2006, Journal of biology.

[85]  M. Berger,et al.  Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors , 2003, Journal of Neuro-Oncology.

[86]  J. Pichler,et al.  Inhibition of TGF-β2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies , 2007 .

[87]  Christian Schichor,et al.  Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines , 2007, Journal of Neuro-Oncology.

[88]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[89]  C. Hawkins,et al.  GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model , 2007, Proceedings of the National Academy of Sciences.

[90]  K. Helin,et al.  Polycomb group protein-mediated repression of transcription. , 2010, Trends in biochemical sciences.

[91]  G. Riggins,et al.  A survey of glioblastoma genomic amplifications and deletions , 2009, Journal of Neuro-Oncology.

[92]  R. Thompson,et al.  Stem cells as vehicles for the treatment of brain cancer. , 2007, Neurosurgery clinics of North America.

[93]  I. Fariñas,et al.  Vascular niche factor PEDF modulates Notch-dependent stemness in the adult subependymal zone , 2009, Nature Neuroscience.

[94]  Ludwin Sk.  Reaction of oligodendrocytes and astrocytes to trauma and implantation. A combined autoradiographic and immunohistochemical study. , 1985 .

[95]  A. Ross,et al.  Cancer esearch apeutics , Targets , and Chemical Biology ecretase Inhibitors Enhance Temozolomide Treatment uman Gliomas by Inhibiting Neurosphere R opulation and Xenograft Recurrence , 2010 .

[96]  Hans Skovgaard Poulsen,et al.  The functional role of Notch signaling in human gliomas. , 2010, Neuro-oncology.

[97]  M. Weller,et al.  Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas. , 2005, Biochemical and biophysical research communications.

[98]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[99]  H. Seol,et al.  The evolution and application of techniques in molecular biology to human brain tumors: a 25 year perspective , 2009, Journal of Neuro-Oncology.

[100]  A. Quiñones‐Hinojosa,et al.  Applications of neural and mesenchymal stem cells in the treatment of gliomas , 2009, Expert review of anticancer therapy.

[101]  P. Kleihues,et al.  Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. , 1988, Journal of neurosurgery.

[102]  A. von Deimling,et al.  The Evolution of Our Understanding on Glioma , 2008, Brain pathology.

[103]  B. Scheithauer,et al.  Diffuse “fibrillary” astrocytomas: correlation of MRI features with histopathologic parameters and tumor grade , 2004, Neuroradiology.

[104]  K. Aldape,et al.  A multigene predictor of outcome in glioblastoma. , 2010, Neuro-oncology.

[105]  Identification of Nepro, a gene required for the maintenance of neocortex neural progenitor cells downstream of Notch , 2009, Development.

[106]  O. Lindvall,et al.  Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke , 2009, Nature Neuroscience.

[107]  Juergen A. Knoblich,et al.  Genome-Wide Analysis of Self-Renewal in Drosophila Neural Stem Cells by Transgenic RNAi , 2011, Cell stem cell.

[108]  D. Stearns,et al.  Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. , 2006, Cancer research.

[109]  E. Holland,et al.  Modeling Adult Gliomas Using RCAS/t-va Technology. , 2009, Translational oncology.

[110]  S. Horvath,et al.  Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant Glioma , 2009, Stem cells.

[111]  M. Hatten.  Central nervous system neuronal migration. , 1999, Annual review of neuroscience.

[112]  Larry Kedes,et al.  HES and HERP families: Multiple effectors of the notch signaling pathway , 2003, Journal of cellular physiology.

[113]  R. Carroll,et al.  Human Bone Marrow‐Derived Mesenchymal Stromal Cells Expressing S‐TRAIL as a Cellular Delivery Vehicle for Human Glioma Therapy , 2009, Stem cells.

[114]  H. Kiyonari,et al.  Glioblastoma Formation from Cell Population Depleted of Prominin1-Expressing Cells , 2009, PloS one.

[115]  S. Ludwin.  Reaction of oligodendrocytes and astrocytes to trauma and implantation. A combined autoradiographic and immunohistochemical study. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[116]  M. Chopp,et al.  The Notch pathway mediates expansion of a progenitor pool and neuronal differentiation in adult neural progenitor cells after stroke , 2009, Neuroscience.

[117]  James E. Goldman,et al.  The interface between glial progenitors and gliomas , 2008, Acta Neuropathologica.

[118]  J. Mathis,et al.  Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma , 2008, Stem cells.

[119]  Magdalena Götz,et al.  Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain , 2008, Proceedings of the National Academy of Sciences.

[120]  R. Gilbertson,et al.  Tumorigenesis in the brain: location, location, location. , 2007, Cancer research.

[121]  A. Berns,et al.  Rapid and Robust Transgenic High-Grade Glioma Mouse Models for Therapy Intervention Studies , 2010, Clinical Cancer Research.

[122]  N. Mongan,et al.  Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. , 2009, Stem cells and development.

[123]  D. Gingras,et al.  The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases. , 2009, Biochemistry.

[124]  A. von Deimling,et al.  Application of Mutant IDH1 Antibody to Differentiate Diffuse Glioma From Nonneoplastic Central Nervous System Lesions and Therapy-induced Changes , 2010, The American journal of surgical pathology.

[125]  Ralph Weissleder,et al.  Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.

[126]  G. Reifenberger,et al.  Molecular Neuropathology of Gliomas , 2009, International journal of molecular sciences.

[127]  H. Kettenmann,et al.  Glioblastoma-Induced Attraction of Endogenous Neural Precursor Cells Is Associated with Improved Survival , 2005, The Journal of Neuroscience.

[128]  P. Eriksson,et al.  Sox-2 is expressed by neural progenitors and astroglia in the adult rat brain , 2004, Neuroscience Letters.

[129]  T. Pierfelice,et al.  Notch, neural stem cells, and brain tumors. , 2008, Cold Spring Harbor symposia on quantitative biology.

[130]  R. Shamir,et al.  Regulatory networks define phenotypic classes of human stem cell lines , 2008, Nature.

[131]  A. Verma.  MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma , 2006 .

[132]  K. Ovaska,et al.  Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme , 2010, Genome Medicine.

[133]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[134]  L. Deangelis,et al.  Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma , 2009, Neurology.

[135]  Joel H. Saltz,et al.  The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas , 2010, PloS one.

[136]  Hai Yan,et al.  Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. , 2010, Journal of the National Cancer Institute.

[137]  M. Westphal,et al.  Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2 , 2008, Clinical Cancer Research.

[138]  Michael Weaver,et al.  Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas , 2003, Journal of Neuro-Oncology.

[139]  H. Blau,et al.  Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation , 2008, Nature Cell Biology.

[140]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[141]  E. Sausville,et al.  Issues and progress with protein kinase inhibitors for cancer treatment , 2003, Nature Reviews Drug Discovery.

[142]  H. Kettenmann,et al.  Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells. , 2010, Brain : a journal of neurology.

[143]  C. Sander,et al.  Automated Network Analysis Identifies Core Pathways in Glioblastoma , 2010, PloS one.

[144]  Y. Wang,et al.  Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. , 2009, Cancer cell.

[145]  H. Blau,et al.  Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[146]  Anthony Asher,et al.  Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma , 2003, Journal of Neuro-Oncology.

[147]  W. Hamel,et al.  Pattern of Recurrence following Local Chemotherapy with Biodegradable Carmustine (BCNU) Implants in Patients with Glioblastoma , 2004, Journal of Neuro-Oncology.

[148]  J. Engh,et al.  Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α , 2009, Oncogene.

[149]  Daniel J. Hoeppner,et al.  Notch signalling regulates stem cell numbers in vitro and in vivo , 2006, Nature.

[150]  S. Vandenberg,et al.  PDGFRα-Positive B Cells Are Neural Stem Cells in the Adult SVZ that Form Glioma-like Growths in Response to Increased PDGF Signaling , 2006, Neuron.

[151]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[152]  Helios Klinikum.  The Antitumorigenic Response of Neural Precursors Depends on Subventricular Proliferation and Age , 2008 .

[153]  A. von Deimling,et al.  The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations , 2011, Brain pathology.

[154]  E. Frenkel,et al.  Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors. , 1980, Neurosurgery.

[155]  S. Temple,et al.  Translating Stem Cell Studies to the Clinic for CNS Repair: Current State of the Art and the Need for a Rosetta Stone , 2011, Neuron.

[156]  Christian HartmannBettina.  Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas , 2010 .

[157]  A. Shiras,et al.  Spontaneous Transformation of Human Adult Nontumorigenic Stem Cells to Cancer Stem Cells Is Driven by Genomic Instability in a Human Model of Glioblastoma , 2007, Stem cells.

[158]  R. Weissleder,et al.  miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. , 2008, Cancer cell.

[159]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[160]  M. Danks,et al.  Stem and progenitor cell-mediated tumor selective gene therapy , 2008, Gene Therapy.